Member Info for share_monster

Well, I guess I've found the answer to my previous question. It's so disappointing to see the share price sub 160 again. To be honest, I didn't think the trading update was too bad apart from Liquidnet. Obviously, the market feels otherwise. Wish a PE fund would stump up the cash and put TCAP out of its prolonged share misery. Such an unbelievable bargain at these levels.

Any views as to where the share price is heading? The recent price weakness doesn't look encouraging.

JPMorgan raises TP ICAP price target to 235 (210) pence - 'overweight'

Peel Hunt also reiterated their Buy recommendation with a 240p price target.

Agree Liquidnet was a little disappointing, but rest of the results were very solid. Nothing in there to justify such a big drop, which makes me conclude it's mainly sentiment from SVB. I think we'll be blue by the end of the day, once sense prevails.

Don't think the drop is specific to the results. All Financials are being hit hard again today following the SVB fallout. This is going to require some patience.

Tree shake ahead of results next week. Barely any sellers. Tells you everything you need to know.

Chunky buying again today. Looking good.

Looks like some serious stakebuilding going on this morning.

Personally, I don't think the management team have done themselves any favours in remaining silent. I would have expected an RNS this morning, simply acknowledging the media reports about failed negotiations regarding the sale of the data division, but reassuring investors they have a clear strategy to realise shareholder value. By remaining silent, they look weak and removed from investors concerns. I wouldn't be surprised if the share price drifts until the Finals. They better be good, otherwise Phase 2 and other institutional investors will be sharpening their knives!!

Totally agree. I'd imagine there must be a pretty good degree of confidence in current trading to justify the decision not to sell the data division. Looking forward to Final results on 14th March.

Seems like an odd decision not to sell Parameta and release shareholder value. Perhaps management have other plans for the business which they're not able to disclose yet. I would have expected much stronger weakness in the share price if investors were genuinely disappointed by the decision. This could be a good opportunity to top up? Personally, I'm fully loaded. My biggest share holding by quite a large margin!

https://www.lse.co.uk/news/TCAP/tp-icap-ditches-talks-over-data-division-sale-report-rc0wl2npckzv99h.html

Unusual share price weakness today, despite market strength. Does anyone know whether there is any news? Thanks.

Seems to have a hard time staying above 180p for any meaningful time. Always seems to be a sell-off early afternoon. I can understand why you're trading it.

Solid trading update and confident outlook. Should rise today.

Agree. Significant contract win. Surprised by the muted share price response. Hopefully the Q3 trading update on Wednesday will get things moving!

I don't think that's an accurate representation since institutions only have to report their net short position if it crosses the 0.5% disclosure threshold. Therefore, they can accumulate multiple short positions at 0.49% under different entities which falls beneath the FCA radar. Hedge funds are pretty smart at hiding what they're really doing. Not saying that's definitely happening here, but 'securities lending' does sound a little suspicious to me.

I'm a little concerned about the 'securities lending' mentioned in the notification. Does that mean Blackrock are lending their shares to other institutions possibly for shorting purposes? Could explain the recent weakness.

Credit Suisse raises Lancashire price target to 725 (675) pence - 'outperform'

Looks promising. Well overdue.